Paul Jablow, The Inquirer (Philly.com) — For researchers, physicians – and patients – prostate cancer has always been among the most maddening and elusive of foes. The third-most common cancer in the United States, behind breast and lung cancers, its course is less predictable than either. It can remain dormant in a man’s body until […]
